Refractory, primary Central Nervous System Neoplasm Active Not Recruiting Phase 1 Trials for Albumin human (DB00062)

Back to Refractory, primary Central Nervous System Neoplasm

Also known as: Refractory Primary Central Nervous System Neoplasm

IndicationStatusPhase
DBCOND0142769 (Refractory, primary Central Nervous System Neoplasm)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02975882Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsTreatment